MTA1 anticorps (C-Term)
Aperçu rapide pour MTA1 anticorps (C-Term) (ABIN1915120)
Antigène
Voir toutes MTA1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 665-715, C-Term
-
Specificité
- Region between residue 665 and the C-terminus (residue 715) of human Metastasis Associated 1 using the numbering given in entry NP_004680.1 (GeneID 9112).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IF (1:250 - 1:1000), IHC, IHC-P (1:500 - 1:2000), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Bladder Cell Carcinoma, Breast Carcinoma, Colon Carcinoma, Non-Small Cell Lung Cancer, Prostate Carcinoma, Testicular Seminoma. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- MTA1 (Metastasis Associated 1 (MTA1))
-
Autre désignation
- MTA1
-
Sujet
-
Name/Gene ID: MTA1
Synonyms: MTA1, Metastasis associated 1 -
ID gène
- 9112
-
Pathways
- Chromatin Binding
Antigène
-